Introduction Welcome to Pharmaprojects’ 2021 review of trends in pharmaceutical R&D. For almost 30 years now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article I’ll examine the state of play at the start of 2021.
Watch Ms. Branon’s lively presentation and discover how central access to one comprehensive source for relevant, timely clinical trial data and trial benchmarks vastly improves your study planning and feasibility processes.
Becoming the “expert to the experts” for your pharma and CRO clients
Using data from the newly redesigned Citeline suite of intelligence tools, Ms. Branon, a member of the Citeline team for over 10 years and Director of Sitetrove, will use her expertise to elucidate the connection between leveraging top-quality intelligence and becoming the “expert to the experts” for your pharma and CRO clients. With her years of experience in the field, especially in site feasibility, staff management, and helping clients develop strategies to identify the most experienced investigators and trial sites, Ms. Branon’s insights are sure to enlighten.
In 2017, Informa Pharma Intelligence took a deep dive into the clinical trial landscape in China over the previous 10 years, in a whitepaper entitled “Is China the Dark Horse in Clinical Development?”. That analysis showed that the number of trial starts in China had been trending upwards year-on-year and suggested that China was on course to become a formidable player within the pharma industry on a global stage.
Topics Clinical Trials
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: